[go: up one dir, main page]

WO2014170842A3 - Substituted alkyl carboxylic acid derivatives as gpr agonists - Google Patents

Substituted alkyl carboxylic acid derivatives as gpr agonists Download PDF

Info

Publication number
WO2014170842A3
WO2014170842A3 PCT/IB2014/060763 IB2014060763W WO2014170842A3 WO 2014170842 A3 WO2014170842 A3 WO 2014170842A3 IB 2014060763 W IB2014060763 W IB 2014060763W WO 2014170842 A3 WO2014170842 A3 WO 2014170842A3
Authority
WO
WIPO (PCT)
Prior art keywords
carboxylic acid
substituted alkyl
acid derivatives
alkyl carboxylic
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2014/060763
Other languages
French (fr)
Other versions
WO2014170842A2 (en
Inventor
Rajiv Sharma
Somnath HALDER
Sanjay Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of WO2014170842A2 publication Critical patent/WO2014170842A2/en
Publication of WO2014170842A3 publication Critical patent/WO2014170842A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to substituted alkyl carboxylic acid derivatives (the compounds of Formula (I)), processes for their preparation, pharmaceutical compositions containing said compounds, their use as GPR (G-protein coupled receptor) agonists, particularly as GPR40 agonists and methods of using these compounds in the treatment of GPR40 mediated diseases or conditions.
PCT/IB2014/060763 2013-04-17 2014-04-16 Substituted alkyl carboxylic acid derivatives as gpr agonists Ceased WO2014170842A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361812784P 2013-04-17 2013-04-17
US61/812,784 2013-04-17

Publications (2)

Publication Number Publication Date
WO2014170842A2 WO2014170842A2 (en) 2014-10-23
WO2014170842A3 true WO2014170842A3 (en) 2015-02-19

Family

ID=50685997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/060763 Ceased WO2014170842A2 (en) 2013-04-17 2014-04-16 Substituted alkyl carboxylic acid derivatives as gpr agonists

Country Status (3)

Country Link
AR (1) AR096041A1 (en)
TW (1) TW201534593A (en)
WO (1) WO2014170842A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566267A (en) * 2016-01-27 2016-05-11 中国药科大学 Novel oxime ether derivative and preparation method thereof and application of derivative by serving as drug
JP7062792B2 (en) 2018-02-13 2022-05-06 ギリアード サイエンシーズ， インコーポレイテッド PD-1 / PD-L1 inhibitor
EP3781556B1 (en) 2018-04-19 2025-06-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
CN118221646A (en) 2018-07-13 2024-06-21 吉利德科学公司 PD-1/PD-L1 inhibitors
KR102635333B1 (en) 2018-10-24 2024-02-15 길리애드 사이언시즈, 인코포레이티드 PD-1/PD-L1 inhibitors
JP2022552655A (en) 2019-10-07 2022-12-19 キャリーオペ，インク． GPR119 agonist
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
JP2023531726A (en) 2020-06-26 2023-07-25 キャリーオペ，インク． AMPK Activator

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008001931A2 (en) * 2006-06-27 2008-01-03 Takeda Pharmaceutical Company Limited Fused cyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070004769A (en) 2004-02-27 2007-01-09 암젠 인코포레이션 Compounds, pharmaceutical compositions, and methods of use thereof for the treatment of metabolic disorders
EP2260017A1 (en) 2008-03-06 2010-12-15 Amgen, Inc Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
ES2450567T3 (en) 2008-10-15 2014-03-25 Amgen, Inc GPR40 spirocyclic modulators
EP2423176A4 (en) 2009-04-22 2012-11-07 Astellas Pharma Inc Carboxylic acid compound
MA34474B1 (en) 2010-07-23 2013-08-01 Connexios Life Sciences Pvt Ltd AGONISTS OF GPR40

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008001931A2 (en) * 2006-06-27 2008-01-03 Takeda Pharmaceutical Company Limited Fused cyclic compounds

Also Published As

Publication number Publication date
TW201534593A (en) 2015-09-16
AR096041A1 (en) 2015-12-02
WO2014170842A2 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
WO2014170842A3 (en) Substituted alkyl carboxylic acid derivatives as gpr agonists
HK1245100A1 (en) Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
EA201501122A1 (en) NEW AGONISTS OF SOMATOSTATIN RECEPTORS OF SUB-TYPE 4 (SSTR4)
PH12017500941A1 (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
HK1244708A1 (en) Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
GEP201706671B (en) Heterocyclyl compounds as mek inhibitors
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
JO3781B1 (en) Quinolone derivatives
MX363127B (en) Benzothiophene derivatives as estrogen receptor inhibitors.
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
PH12016500885A1 (en) Novel heterocyclic compounds
IN2014MN00697A (en)
PH12016500394A1 (en) Polymorphic form of pyrrole derivative and intermediate thereof
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
MY192609A (en) Substituted bicyclic heteroaryl compounds as rxr agonists
WO2014159061A3 (en) Benzo-fused heterocyclic derivatives useful as agonists of gpr120
CY1120744T1 (en) AZAINDOLIS ACETIC ACID PRODUCERS AND THE USE OF THESE AS REGULATORY PROSTAGLANDIN RECEPTORS D2
PH12015502717B1 (en) Anti-fibrogenic compounds, methods and uses thereof
EA201790522A1 (en) SALT OF DERIVATIVE CEFALOSPORIN, ITS CRYSTAL SOLID MATTER AND METHOD OF ITS PREPARATION
MX2016011900A (en) Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators.
MX351994B (en) Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5 -carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl]-amide.
WO2015001565A3 (en) "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof"
EA201590452A1 (en) SALT COMPOUNDS OF BENZOTHIAZOLONE AS AGONISTS OF β-2-ADRENORECEPTORS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14722771

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14722771

Country of ref document: EP

Kind code of ref document: A2